ES2531324T3 - Intermedio para producir un derivado de gamma-aminoácido bicíclico - Google Patents

Intermedio para producir un derivado de gamma-aminoácido bicíclico Download PDF

Info

Publication number
ES2531324T3
ES2531324T3 ES13177681T ES13177681T ES2531324T3 ES 2531324 T3 ES2531324 T3 ES 2531324T3 ES 13177681 T ES13177681 T ES 13177681T ES 13177681 T ES13177681 T ES 13177681T ES 2531324 T3 ES2531324 T3 ES 2531324T3
Authority
ES
Spain
Prior art keywords
produce
amino acid
acid derivative
bicyclic
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13177681T
Other languages
English (en)
Inventor
Kousei Shimada
Asuka Kawamura
Naohisa Arakawa
Yuki Domon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of ES2531324T3 publication Critical patent/ES2531324T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/613—Unsaturated compounds containing a keto groups being part of a ring polycyclic
    • C07C49/617—Unsaturated compounds containing a keto groups being part of a ring polycyclic a keto group being part of a condensed ring system
    • C07C49/623—Unsaturated compounds containing a keto groups being part of a ring polycyclic a keto group being part of a condensed ring system having two rings
    • C07C49/627—Unsaturated compounds containing a keto groups being part of a ring polycyclic a keto group being part of a condensed ring system having two rings the condensed ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/32—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/93—Spiro compounds
    • C07C2603/94—Spiro compounds containing "free" spiro atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)

Abstract

Un compuesto representado por la fórmula general (1):**Fórmula** en la que R1, R2, R2', R4, R5, R8 y R8' son cada uno independientemente un átomo de hidrógeno; y R3 es un grupo etilo.
ES13177681T 2007-09-28 2008-09-25 Intermedio para producir un derivado de gamma-aminoácido bicíclico Active ES2531324T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007255430 2007-09-28

Publications (1)

Publication Number Publication Date
ES2531324T3 true ES2531324T3 (es) 2015-03-13

Family

ID=40511336

Family Applications (2)

Application Number Title Priority Date Filing Date
ES13177681T Active ES2531324T3 (es) 2007-09-28 2008-09-25 Intermedio para producir un derivado de gamma-aminoácido bicíclico
ES08833399T Active ES2433890T3 (es) 2007-09-28 2008-09-25 Derivado de aminoácido bicíclico

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES08833399T Active ES2433890T3 (es) 2007-09-28 2008-09-25 Derivado de aminoácido bicíclico

Country Status (26)

Country Link
US (1) US7947738B2 (es)
EP (2) EP2192109B1 (es)
JP (1) JP4479974B2 (es)
KR (2) KR101409079B1 (es)
CN (2) CN101878193B (es)
AU (1) AU2008304933B2 (es)
BR (2) BRPI0818193B8 (es)
CA (1) CA2701110C (es)
CO (1) CO6270314A2 (es)
CY (1) CY1114836T1 (es)
DK (1) DK2192109T3 (es)
ES (2) ES2531324T3 (es)
HK (2) HK1139381A1 (es)
HR (1) HRP20130935T1 (es)
IL (1) IL204621A (es)
MX (1) MX2010003394A (es)
MY (2) MY153910A (es)
NZ (1) NZ584699A (es)
PH (1) PH12013501663A1 (es)
PL (1) PL2192109T3 (es)
PT (1) PT2192109E (es)
RU (1) RU2446148C2 (es)
SI (1) SI2192109T1 (es)
TW (2) TWI436762B (es)
WO (1) WO2009041453A1 (es)
ZA (1) ZA201002013B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2192109B1 (en) 2007-09-28 2013-09-04 Daiichi Sankyo Company, Limited Bicyclic -amino acid derivative
WO2010079668A1 (ja) * 2009-01-08 2010-07-15 第一三共株式会社 オレフィン化合物
JP5557292B2 (ja) 2009-03-26 2014-07-23 第一三共株式会社 二環性γ−アミノ酸誘導体の製造方法
KR101816336B1 (ko) 2011-06-08 2018-01-08 다이이찌 산쿄 가부시키가이샤 이미늄염을 경유하는 2 고리성 화합물의 제조 방법
EP2719677B1 (en) * 2011-06-08 2017-09-06 Daiichi Sankyo Company, Limited Method for producing bicyclic compound via claisen rearrangement
ES2686929T3 (es) 2011-12-15 2018-10-22 Daiichi Sankyo Company, Limited Procedimiento de resolución óptica para compuesto bicíclico utilizando catalizador asimétrico
WO2013089189A1 (ja) * 2011-12-16 2013-06-20 第一三共株式会社 ヒドロキシスルホン酸を経由する二環性化合物の光学分割方法
JP5947821B2 (ja) * 2012-02-08 2016-07-06 ステラファーマ株式会社 セレウリドおよびその誘導体の製造方法、セレウリド製造の為の中間体ならびにセレウリド誘導体
JP6023794B2 (ja) * 2012-04-10 2016-11-09 第一三共株式会社 酵素を用いる二環性化合物の光学分割方法
IN2014MN02116A (es) * 2013-04-04 2015-09-04 Daiichi Sankyo Companyltd
TWI635071B (zh) 2013-07-08 2018-09-11 第一三共股份有限公司 光學活性二環γ－胺基酸衍生物及其製造方法
CN109721562A (zh) * 2013-12-18 2019-05-07 诺瓦色生物公司 用于治疗疼痛和其它病症的γ-氨基丁酸(GABA)类似物
JP6630344B2 (ja) 2015-03-19 2020-01-15 第一三共株式会社 着色剤を含有する固形製剤
WO2016148263A1 (ja) 2015-03-19 2016-09-22 第一三共株式会社 抗酸化剤を含有する固形製剤
WO2017107907A1 (zh) * 2015-12-25 2017-06-29 四川海思科制药有限公司 稠合环γ-氨基酸衍生物及其制备方法和在医药上的应用
CN106928080B (zh) * 2015-12-31 2020-12-25 四川海思科制药有限公司 稠合环γ-氨基酸衍生物及其制备方法和在医药上的应用
CN107848952B (zh) * 2015-12-31 2021-04-09 四川海思科制药有限公司 稠合三环γ-氨基酸衍生物及其制备方法和在医药上的应用
WO2017183539A1 (ja) * 2016-04-18 2017-10-26 第一三共株式会社 メルドラム酸を用いる二環性化合物の製造方法
TW201806928A (zh) * 2016-07-01 2018-03-01 第一三共股份有限公司 胺基羧酸之酸加成鹽的結晶及其製造方法
WO2018014869A1 (zh) * 2016-07-21 2018-01-25 正大天晴药业集团股份有限公司 作为crth2抑制剂的吲哚衍生物
CA3035121C (en) * 2016-09-14 2021-02-16 Sichuan Haisco Pharmaceutical Co., Ltd. Fused tricyclic .gamma.-amino acid derivative, preparation method therefor, and medical use thereof
JP7051332B2 (ja) * 2017-08-23 2022-04-11 キヤノン株式会社 有機化合物及び光電変換素子
EA202190126A1 (ru) * 2018-07-12 2021-06-30 Сычуань Хайско Фармасьютикал Ко., Лтд. Композиция конденсированных трициклических производных гамма-аминокислоты и её приготовление
TW202019871A (zh) * 2018-07-12 2020-06-01 大陸商四川海思科製藥有限公司 稠合三環γ-胺基酸衍生物鹽類之晶型、製備方法及其用途
JP7312751B2 (ja) * 2018-07-30 2023-07-21 第一三共株式会社 安定化剤を含有する医薬品の固形製剤
CN112384493B (zh) * 2018-08-09 2023-06-06 四川海思科制药有限公司 稠合三环γ-氨基酸衍生物的制备方法及中间体
CN114402198A (zh) * 2019-09-03 2022-04-26 四川海思科制药有限公司 2-((1s,2s,3r,6s,8s)-2-(氨甲基)三环[4.2.1.03,8]壬烷-2-基)乙酸苯磺酸盐或其组合物杂质检测方法
CN110511141B (zh) * 2019-09-09 2022-04-29 上海凌凯医药科技有限公司 一种丙戊酰脲的合成方法
US20220296548A1 (en) * 2019-10-25 2022-09-22 Kyoto University Preventative or therapeutic agent for tauopathy
CN110818582B (zh) * 2019-11-20 2023-06-09 合肥拓锐生物科技有限公司 一种gaba类似物及其盐，及其合成方法、应用、药物
CN111116345A (zh) * 2019-12-30 2020-05-08 上海华理生物医药股份有限公司 一种制备Mirogabalin的新方法
CA3216507A1 (en) 2021-05-12 2022-11-17 Boehringer Ingelheim International Gmbh Pyridine derivatives with c-linked cyclic substituents as cgas inhibitors
CN114195661B (zh) * 2021-12-21 2023-12-22 苏州楚凯药业有限公司 一种苯磺酸米洛巴林的制备方法
CN117986143A (zh) * 2022-11-03 2024-05-07 中科中山药物创新研究院 含有多环结构的γ-氨基丁酸衍生物及其制备方法和用途
CN116903468B (zh) * 2023-07-14 2024-01-26 山东新时代药业有限公司 一种米洛巴林中间体的制备方法
CN117800858A (zh) * 2023-12-28 2024-04-02 南京津泓科技有限公司 一种米洛巴林催化氰基化制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19547766A1 (de) * 1995-12-20 1997-06-26 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
KR100589066B1 (ko) 1997-10-27 2006-06-13 워너-램버트 캄파니 엘엘씨 약제로서 유용한 시클릭 아미노산 및 그의 유도체
HN2000000224A (es) 1999-10-20 2001-04-11 Warner Lambert Co Aminoacidos biciclicos como agentes farmaceuticos
GB2374595A (en) * 2001-04-19 2002-10-23 Warner Lambert Co Fused bicyclic or tricyclic amino acids
EP1379494B1 (en) 2001-04-19 2010-03-10 Warner-Lambert Company LLC Fused bicyclic or tricyclic amino acids
WO2004006836A2 (en) 2002-07-11 2004-01-22 Merck & Co., Inc. Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds
GB0223072D0 (en) * 2002-10-04 2002-11-13 Pfizer Ltd Cyclic nitromethyl acetic acid derivatives
US8168181B2 (en) * 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
EP2192109B1 (en) 2007-09-28 2013-09-04 Daiichi Sankyo Company, Limited Bicyclic -amino acid derivative

Also Published As

Publication number Publication date
PH12013501663B1 (en) 2015-02-09
BRPI0818193B8 (pt) 2021-05-25
BR122013020635A2 (pt) 2019-08-06
TW200924743A (en) 2009-06-16
KR101335784B1 (ko) 2013-12-05
HK1139381A1 (en) 2010-09-17
KR20100065342A (ko) 2010-06-16
BRPI0818193B1 (pt) 2020-11-10
CA2701110A1 (en) 2009-04-02
RU2446148C2 (ru) 2012-03-27
CA2701110C (en) 2013-01-08
BRPI0818193A2 (pt) 2017-12-12
CY1114836T1 (el) 2016-12-14
TWI526425B (zh) 2016-03-21
HK1190698A1 (en) 2014-07-11
IL204621A (en) 2013-04-30
MX2010003394A (es) 2010-04-09
TW201439053A (zh) 2014-10-16
NZ584699A (en) 2011-04-29
HRP20130935T1 (hr) 2013-11-22
EP2192109B1 (en) 2013-09-04
DK2192109T3 (da) 2013-12-16
MY172034A (en) 2019-11-12
EP2192109A1 (en) 2010-06-02
CO6270314A2 (es) 2011-04-20
KR20130093181A (ko) 2013-08-21
US7947738B2 (en) 2011-05-24
ZA201002013B (en) 2010-11-24
TWI436762B (zh) 2014-05-11
JPWO2009041453A1 (ja) 2011-01-27
PL2192109T3 (pl) 2014-01-31
RU2010116708A (ru) 2011-11-10
PH12013501663A1 (en) 2015-02-09
US20100249229A1 (en) 2010-09-30
PT2192109E (pt) 2013-12-09
AU2008304933B2 (en) 2011-02-24
EP2657219A1 (en) 2013-10-30
EP2192109A4 (en) 2012-04-18
JP4479974B2 (ja) 2010-06-09
IL204621A0 (en) 2010-11-30
ES2433890T3 (es) 2013-12-12
WO2009041453A1 (ja) 2009-04-02
AU2008304933A1 (en) 2009-04-02
SI2192109T1 (sl) 2014-03-31
KR101409079B1 (ko) 2014-06-18
CN101878193B (zh) 2014-07-09
CN103483169A (zh) 2014-01-01
EP2657219B1 (en) 2014-12-10
MY153910A (en) 2015-04-15
CN101878193A (zh) 2010-11-03

Similar Documents

Publication Publication Date Title
ES2531324T3 (es) Intermedio para producir un derivado de gamma-aminoácido bicíclico
ES2571483T3 (es) Producto intermedio para producir un éster de ácido sulfónico cíclico
ECSP14013245A (es) Nuevos derivados dihidroquinolina-2-ona
UY31093A1 (es) Compuestos de ariloazol-2-il cianoetilamino, método para prepararlos y método para utilizarlos
DOP2009000039A (es) COMPUESTOS DE PIRIDO (2,3-D) PIRIMIDINONA Y SU USO COMO INHIBIDORES DE P13-Ka
CU20110204A7 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
CU23840B1 (es) Nuevos derivados de sulfonamida como antagonistas de la bradiquinina
PE20120495A1 (es) 3-ciclopentilamino-2,2-difluor-propanoato de etilo como intermediario en la preparacion de pirimidodiazepinas
CR10233A (es) Piridin-4-ilmetilamidas
ECSP10010195A (es) Derivados de indolinona y procedimiento para su fabricación
SV2011003800A (es) Derivados de piridino-piridinonas, su preparacion y su aplicacion en terapeutica
UY31712A1 (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen
ECSP099791A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparación y su aplicación en terapéutica
PA8855001A1 (es) Monocarbamas
BR112013010850A8 (pt) Composto de etinilfenilamidina ou sal do mesmo, método para produzir o mesmo e fungicida para uso agrícola e em horticultura
ECSP109961A (es) Derivados de indol-2-ona disustituidos en 3, su preparación y su aplicación en terapéutica
SV2008002512A (es) Derivados de aminoacidos ref. pc32769a
CR20110111A (es) Composicion farmaceutica solida
UY30740A1 (es) Nuevo procedimiento para la preparacion de 4,4??-( 1-metil-1,2-etandilil)-bis-(2,6-piperazindiona)
CR20150272A (es) Derivado de hidantoina
UY29879A1 (es) Derivados de 6-heteroarilpiridoindolona, su preparación y su aplicación en terapéutica
AR051936A1 (es) Proceso para la preparacion de pirazoles
BRPI0512236A (pt) processos para a preparação de 6-alquil-5-arilsulfonil-diidrofenantridinas
CR11448A (es) Moduladores de y-secretasa con elances de carbono